A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC
SOCRATES HCC will investigate whether a radiotherapy technique (called SABR) can treat early stage liver cancer more effectively than current treatments which use heating probes directly inserted into the tumour or chemotherapy or radioactive particles injected into the blood supply of the tumour.
Primary Sponsor
Collaborating Groups
Australasian Gastro-Intestinal Trials Group (AGITG), Abdominal Radiology Group of Australia and New Zealand (ARGANZ) & Gastrointestinal Society of Australia (GESA)
Participating Centres
Accrual Target
218
Current Accrual
Trial Chairperson
Prof Alan Wigg, Flinders Medical Centre, SA, Australia
A/Prof David Pryor, Princess Alexandra Hospital, QLD, Australia
Trial Contact
SOCRATES_HCC@trog.com.au
Clinical Trial Registration
Related Post
Recruitment Milestone Achieved for TROG 19.06 DECREASE Trial
TRIAL UPDATE: 8 July 2025 The TROG 19.06 DECREASE
Cancer Survivor to Take on Fifth Kokoda trek to Support TROG
LATEST NEWS: 26 June 2025 He may be 76
